Cite

    Guo, J. et al. (2023). Circulating tumor necrosis factor‐α, interleukin‐1β, and interleukin‐17A estimates increased major adverse cardiac event risk in acute myocardial infarction patients. Journal of clinical laboratory analysis. 37 (5), p. n/a. [Online].